Upon induction of differentiation, growth-arrested (G1 phase) 3T3-L1 preadipocytes express CCAAT/enhancer binding protein-␤ (C/EBP␤), initiating a transcriptional cascade. C/EBP␤ immediately undergoes a priming phosphorylation (on Thr188) by MAPK/ERK. However, the acquisition of DNA binding and transactivation capacity of C/EBP␤ is delayed until further phosphorylation (on Ser 184 or Thr179) by GSK3␤ occurs. Phosphorylation by glycogen synthase kinase-3␤ (GSK3␤) induces S phase entry and thereby mitotic clonal expansion (MCE), a requirement for terminal differentiation. Because MAPK activity is down-regulated before S phase is completed, we sought to identify the kinase that maintains C/EBP␤ in the primed phosphorylated state throughout S phase and MCE. We show here that cdk2/cyclinA, whose expression is activated at the onset of S phase, functions in this capacity. Ex vivo and in vitro experiments show that cdk2/cyclinA catalyzes this delayed priming phosphorylation. Mass spectrometric analysis revealed that cdk2/cyclinA phosphorylates C/EBP␤ on Thr188 and is required for phosphorylation (on Ser184 or Thr179) of C/EBP␤ by GSK3␤ and maintenance of DNA binding activity. Suppression of cdk2 activity by RNA interference or pharmacologic inhibitor disrupts subsequent events in the differentiation program. Thus, MAPK and cdk2/cyclinA act sequentially to maintain Thr188 of C/EBP␤ in the primed phosphorylated state during MCE and thereby progression of terminal differentiation.
W
hen induced to differentiate, growth-arrested 3T3-L1 preadipocytes in G 1 phase synchronously reenter the cell cycle, undergo two rounds of mitosis [(mitotic clonal expansion (MCE)], then exit the cell cycle and commence terminal differentiation into adipocytes (1, 2) . Fourteen hours after induction, preadipocytes traverse the G 1 /S checkpoint as evidenced by the expression/activation of cdk2 and cyclinA, the turnover of p27/ kip1, hyperphosphorylation of Rb protein, translocation of glycogen synthase kinase-3␤ (GSK3␤) into the nucleus and cyclinD1 from the nucleus, and incorporation of [ 3 H]thymidine into DNA (1) . Blocking these steps disrupts MCE and progression of the differentiation program. The synchrony by which 3T3-L1 preadipocytes proceed through MCE has been invaluable in delineating the sequence of events that occur early in the adipocyte differentiation program (2, 3) .
Upon induction of differentiation CCAAT/enhancer binding protein-␤ (C/EBP␤) is expressed immediately (Յ2 h), triggering a transcriptional cascade by transcriptionally inducing the expression of C/EBP␣ and peroxisome proliferator-activated receptor ␥ (PPAR␥) (4) (5) (6) (7) . C/EBP␣ and PPAR␥ are pleiotropic transcriptional activators of genes that give rise to the adipocyte phenotype (4, (8) (9) (10) . Although C/EBP␤ is expressed Յ2 h after induction, it lacks DNA-binding and transactivation activity (11) . These activities are acquired only after a long (Ն14 h) lag. Acquisition of DNA binding activity occurs concomitant with the entry of S phase at the G 1 /S checkpoint and the onset of MCE (11) . This lag appears to be required, because C/EBP␣ is antimitotic (12) (13) (14) and its premature expression would otherwise prevent MCE, during which chromatin remodeling is thought to provide access of C/EBP␣ and PPAR␥ to adipocyte gene promoters. It should be noted that sequestration of C/EBP␤ with a dominant-negative A-Zip blocks its entry into the nucleus, preventing MCE and thus terminal differentiation (15) . Likewise, MCE and terminal differentiation are disrupted in C/EBP␤ Ϫ/Ϫ mouse embryo fibroblasts (16) . Previous studies have shown that C/EBP␤ is sequentially phosphorylated during differentiation of 3T3-L1 adipocytes (3), first by MAPK (on Thr 188 ) in G 1 phase and later by GSK3␤ (on Ser 184 or Thr 179 ) at the onset of S phase concurrent with the translocation of GSK3␤ into the nucleus. Phosphorylation of Thr 188 appears to prime C/EBP␤ for subsequent phosphorylation on Ser 184 or Thr 179 , which lie immediately upstream of the priming site. Recent studies indicate that this dual phosphorylation induces a conformational change in C/EBP␤ that allows dimerization through its C-terminal leucine zipper domain (17) . Dimerization brings the adjacent apposing basic regions into position to hold the C/EBP regulatory element of the gene in a ''scissors-like'' grip as suggested by McKnight and colleagues (18) . Together, these actions are believed to facilitate acquisition of DNA-binding activity and transcription.
However, because expression of MAPK activity is transient and abruptly decreases 14-16 h after induction, the following question must be considered: How is the ''priming'' phosphorylation at Thr 188 maintained during the subsequent period of S phase and MCE when dual phosphorylation by GSK3␤ occurs? This issue is addressed in the present paper. Here we show that in both cellular and in vitro contexts, C/EBP␤ undergoes phosphorylation on Thr 188 by cdk2/cyclinA, which primes the target region for further phosphorylation by GSK3␤. Together, these phosphorylations give rise to DNA binding activity. Our results indicate that MAPK and cdk2/cyclinA act sequentially to maintain Thr 188 of C/EBP␤ in the primed phosphorylated state for phosphorylation by GSK3␤ throughout MCE.
Thr 188 after induction of differentiation (Fig. 1A) . This priming phosphorylation at Thr 188 is catalyzed by MAPK and required for subsequent phosphorylation by GSK3␤ and the acquisition of DNA binding activity by C/EBP␤ (3). MAPK/ERK itself is rapidly (Յ1 h) phosphorylated/activated after induction of differentiation (Fig. 1B) (3) . Although phosphorylation of C/EBP␤ on Thr 188 persists at a high level for Ͼ24 h ( Fig. 1 A and ref. 3), the phosphorylation/activity of MAPK [phospho-ERK (P-ERK)] falls off abruptly after 10-12 h. This finding raises the question of how this priming phosphorylation, which is required for subsequent phosphorylation by GSK3␤ (3), is maintained throughout S phase and MCE. Several findings suggested cdk2 as the candidate priming kinase for S phase progression. First, cdk2 is known to phosphorylate rat C/EBP␤ on Thr 189 [equivalent to Thr 188 in mouse C/EBP␤ (19) ]. Furthermore, the expression of both cdk2 and cyclinA is coordinately activated, concomitant with the turnover of p27/kip (a cdk2/cyclinA inhibitor) during this time window of the differentiation program (1).
To determine whether cdk2/cyclinA has the potential to act as the priming kinase, cdk2/cyclinA was immunoprecipitated from 3T3-L1 cells 20 h after induction and the decline of P-ERK/ MAPK (Fig. 1B) . It is evident that, at 20 h, cdk2/cyclinA is active as indicated by its ability to phosphorylate both histone H1 ( Fig.  2A) and purified rC/EBP␤ (Fig. 2B) . Furthermore, treatment of the cells with roscovitine, a potent cdk2/cyclinA inhibitor, rapidly reduces the phosphorylation of C/EBP␤ (see below).
In vitro experiments with recombinant C/EBP␤ and [␥-32 P]ATP verified that cdk2/cyclinA phosphorylates C/EBP␤ (Fig. 3A) that phosphorylation occurs on Thr 188 (Fig. 3B ) as it does with MAPK (3). To ascertain the number of sites phosphorylated by cdk2/cyclinA (or MAPK), the reaction products Changes in the levels of C/EBP␤, ERK, and cdk2 and phosphorylation states of C/EBP␤/Thr 188 and ERK during differentiation of 3T3-L1 preadipocytes. Two-day postconfluent 3T3-L1 preadipocytes were induced to differentiate, and cell extracts were prepared, subjected to SDS/PAGE, and immunoblotted with antibodies to C/EBP␤, P-Thr188-C/EBP␤ (A), ERK, P-ERK (B), and cdk2 (C); relative levels are plotted (D).
were separated by SDS/PAGE, and the protein band corresponding to C/EBP␤ was excised, digested with trypsin, and subjected to mass spectrometry. Nanospray MS showed that phosphorylation of rC/EBP␤ by either cdk2/cyclinA or MAPK gave rise to a singly phosphorylated triply charged species of the correct mass (m/z, 1,094.8) (Fig. 3C Middle and Bottom). Identification of the phosphorylation site was also verified by mass spectrometry. The site phosphorylated by cdk2/cyclinA [supporting information (SI) Fig. 8 32 P]ATP leads to phosphorylation of purified rC/EBP␤, whereas in the absence of cdk2/cyclinA, GSK3␤ alone does not support phosphorylation (Fig. 4A) . Incubation with cdk2/cyclinA (or MAPK) in combination with GSK3␤ produced a level of phosphorylation approximately twice that by cdk2/cyclinA or MAPK alone (Fig. 4A ). This finding indicates that phosphorylation by cdk2/cyclinA (or MAPK) primes C/EBP␤ for further phosphorylation by GSK3␤. It should also be noted that phosphorylation by cdk2/cyclinA (or MAPK) slows the mobility of C/EBP␤ slightly (Figs. 4A and 5A) and that dual phosphorylation by cdk2/cyclinA (or MAPK) and GSK3␤ slows it even more (Fig. 5A) .
The extent of phosphorylation of rC/EBP␤ by the combined kinases was verified by mass spectrometry. After separation by SDS/PAGE, the protein band corresponding to C/EBP␤ was excised, digested with trypsin, and subjected to nano liquid chromatography (LC)-MS/MS analysis. This analysis identified a doubly phosphorylated peptide (m/z, 1,121.0) when C/EBP␤ was incubated with both cdk2/cyclinA and GSK3␤ or both MAPK and GSK3␤ (Fig. 4B) . To identify the specific amino acids in rC/EBP␤ phosphorylated in vitro, experiments similar to those above were performed. MS/MS analysis of C/EBP␤ incubated with cdk2/cyclinA and GSK3␤ revealed two doubly phosphorylated peptide species, one phosphorylated at Thr 188 and Ser 184 (SI Fig. 9 ) and another phosphorylated at Thr 188 and Ser 179 (data not shown). No phosphorylation product was detected with GSK3␤ alone. Together, these findings show that C/EBP␤ can also be phosphorylated at Thr 188 by cdk2/cyclinA and that this phosphorylation serves as the priming site for phosphorylation at Ser 184 /Thr 179 by GSK3␤ in vitro. It should be noted that we showed in ref.
3 that 20-24 h after induction of differentiation of 3T3-L1 preadipocytes, the time window in which MAPK activity is low and cdk2/cyclinA activity is high (Fig. 2 A and B) , both doubly phosphorylated C/EBP␤ peptide species (Thr 188 and Ser 184 or Thr 179 ) are present.
Dual Phosphorylation of C/EBP␤ by cdk2/cyclinA and GSK3␤ Leads to
Acquisition of DNA-Binding Activity. To determine the effect of phosphorylation of rC/EBP␤ by cdk2/cyclinA with or without GSK3␤ on DNA-binding activity, an experiment identical to that described in Fig. 4 was performed. DNA binding activity was assessed by EMSA with a labeled oligonucleotide corresponding to the C/EBP-binding site in the C/EBP␣ gene promoter (7). DNA-binding activity was acquired only when C/EBP␤ was phosphorylated by both cdk2/cyclinA and GSK3␤ (Fig. 5B) . Unphosphorylated C/EBP␤ or C/EBP␤ phosphorylated by cdk2/ cyclinA or MAPK alone had no effect on DNA-binding activity. Together, these results show that dual phosphorylation of C/EBP␤ on Thr 188 by cdk2/cyclinA and on Ser 184 or Thr 179 by GSK3␤ is required for the acquisition of DNA-binding activity and that phosphorylation by cdk2/cyclinA alone is insufficient to increase DNA binding activity. 
Suppression of cdk2 Activity or Expression Decreases Phosphorylation
of C/EBP␤ at Thr188 and Blocks MCE and Differentiation. Brief exposure (4 h) of 3T3-L1 preadipocytes to the potent cdk2 inhibitor, roscovitine, as the cells enter S phase (1) markedly lowers phosphorylation of Thr 188 in C/EBP␤ (Fig. 6 A and B) . Although the level of C/EBP␤ was also partially lowered by inhibitor treatment, the level of phosphorylation was more drastically affected, raising the possibility that the turnover of C/EBP␤ may be preceded and accelerated by phosphorylation. It should be noted that, in previous experiments (1), we showed that treatment with roscovitine in this time window blocked MCE, the expression of differentiation markers, and acquisition of adipocyte characteristics.
Reducing the expression of cdk2 by RNA interference had similar effects. Several siRNA oligonucleotides (23 mers), corresponding to diverse regions in the cdk2 mRNA sequence, were tested initially for their ability to silence cdk2 expression. The most active of these oligonucleotides virtually abolished expression of cdk2 (Fig. 7A) . Proliferating 3T3-L1 preadipocytes were exposed to this oligonucleotide and later treated with differentiation inducers (at confluence) under conditions similar to those of the standard differentiation protocol. As shown in Fig.  6 C and D, lowering cdk2 by RNA interference almost completely blocked the phosphorylation of Thr 188 in C/EBP␤. Consistent with the results with roscovitine (see above), blocking phosphorylation of Thr 188 only partially reduced the level of C/EBP␤ (Fig. 6A and 7A) . Moreover, suppressing expression of cdk2 or C/EBP␤ by RNA interference blocked MCE (Fig. 7B) , suppressed the expression of differentiation markers (Fig. 7D) , and prevented the accumulation of cytoplasmic triglyceride (Fig.   7C ), an indicator of adipogenesis. Taken together, these findings suggest that cdk2, which catalyzes the priming phosphorylation of Thr 188 in C/EBP␤ (Figs. 3-5) , is required for MCE and differentiation. It should be noted that because cdk2 has other roles, it is possible that its inactivation also acts at another site in the cell cycle.
Discussion
During differentiation of 3T3-L1 preadipocytes C/EBP␤ undergoes a priming phosphorylation on Thr 188 followed by an additional phosphorylation on Ser 184 or Thr 179 by GSK3␤ to produce dually phosphorylated species that bind to and transactivate genes that produce the adipocyte phenotype (4, (8) (9) (10) . In this paper, we show that the priming phosphorylation occurs at two points in the differentiation program: an initial phosphorylation by MAPK followed much later by phosphorylation by cdk2/ cyclinA when MAPK activity has disappeared. Both priming phosphorylations occur independently on Thr 188 as demonstrated in in vitro experiments with rC/EBP␤ and the purified kinases (Figs. 2-4 ). Phosphorylation at this site is required but is insufficient for the acquisition of DNA binding function; DNA binding requires a further phosphorylation by GSK3␤ (Fig. 5) , as discussed above. We have shown that dual phosphorylation of Thr 188 and of Ser 184 induces a conformational change that facilitates dimerization of C/EBP␤ monomers, creating a DNA binding pocket that can bind the C/EBP regulatory element in DNA and support transactivation (17) .
The phosphoryl group (phospho-Thr 188 ) on C/EBP␤, introduced by MAPK, turns over rapidly during the period (2-12 h after induction of differentiation) in which MAPK/P-ERK activity decreases. Rapid turnover of phospho-Thr 188 is indicated by its rapid rate of decline when cdk2 is down-regulated by RNA interference (Fig. 7 A and B) . Because the level of P-Thr 188 -C/ EBP␤ remains relatively constant during this time window (Fig.  1D) , it is evident that normally cdk2 takes over this function (phosphorylation of C/EBP␤ on Thr 188 ), thereby compensating for the loss of MAPK activity. The effectiveness of the RNAi knockdown of cdk2 is indicated by the fact that the terminal steps in the differentiation program including MCE (Fig. 7B) , i.e., the expression of key adipocyte differentiation markers (Fig. 7D) and acquisition of the adipose phenotype, are blocked (Fig. 7C ) when cdk2 expression is suppressed (Fig. 7A ). This finding also shows that priming by MAPK cannot replace priming by cdk2/ cyclinA. The requirement of MAPK for the successful initiation of terminal differentiation has also been demonstrated in earlier studies by the use of potent MAPK inhibitors (1) . Together, these findings illustrate the importance of both priming phosphorylations of C/EBP␤ in orchestrating the differentiation program. It is now clear that maintaining Thr 188 in the primed/ phosphorylated state throughout MCE, is necessary to ensure phosphorylation by GSK3␤. Because cdk2 has other roles, it is possible that its inactivation could act at another point in the cell cycle and thereby affect differentiation. It is worthy of note that C/EBP␤ can also be phosphorylated by cdk2 at other sites, i.e., S 64 and T 189 , in another context, i.e., in Ras-transformed NIH cells (19) .
It should be noted that this is unlike the situation in mouse liver where phosphorylation at a different site (S 239 ) in C/EBP␤ causes exit from the nucleus to the cytoplasm (20) . This change of intracellular localization was attributed to phosphorylation at a site adjacent to/within the nuclear localization sequence (nls). Hence, exit from the nucleus correlated with phosphorylation. Because cdk2 phosphorylates C/EBP␤ on T 188 , which is immediately succeeded by further phosphorylation (as above) on Ser 184 or Thr 179 sites not located at the nls, a change in localization would not be expected. We have shown that dimerization of C/EBP␤ with A-C/EBP, which obscures the nls, prevents nuclear entry C/EBP␤ and thereby a blockade of subsequent events in the differentiation program that involve C/EBP␤, e.g., mitotic clonal expansion, expression of adipocyte genes, and the accumulation of cytoplasmic fat (15) .
It is formally possible that one of these kinases targets an additional, as-yet unidentified phosphorylation site in C/EBP␤. Although only a single tryptic peptide product, phosphorylated (on Thr 188 ) of MAPK or cdk2/cyclinA, was detected in our analysis (Fig. 4) , it is possible that another phosphopeptide species has eluded detection by mass spectrometry. Although we have searched for other phosphorylated tryptic peptide species by mass spectrometry, to date only one phosphopeptide, derived from kinase-treated rC/EBP␤, has been identified, i.e., that phosphorylated on Thr 188 .
It should also be noted that C/EBP␤ has two known functions in the adipocyte differentiation program, i.e., the induction of MCE (15, 16) and transactivation of C/EBP␣ and PPAR␥ (4-7). Thus, it is conceivable that these distinct functions require phosphorylation at two different sites. Were this the case, different phosphorylated species C/EBP␤ might function at these points in the differentiation program. Whether this occurs must await further investigation.
Materials and Methods
Cell Culture and Induction of Differentiation. 3T3-L1 preadipocytes were propagated and maintained in DMEM containing 10% (vol/vol) calf serum as described in ref. 21 . To induce differentiation, 2-day postconfluent/G 1 phase preadipocytes (designated day 0) were fed DMEM containing 10% (vol/vol) FBS (FBS), 1 g/ml insulin, 1 M dexamethasone, and 0.5 mM 3-isobutyl-1-methylxanthine (MDI) until day 2. Cells were then fed DMEM supplemented with 10% FBS and 1 g/ml insulin for 2 days, after which they were fed every other day with DMEM containing 10% FBS. Adipocyte gene expression and acquisition of the adipocyte phenotype begins on day 3 and is maximal by day 8.
Western Blotting. To follow changes in the level of C/EBP␤, P-Thr 188 -C/EBP␤, MAPK(ERK), P-ERK and cdk2 proteins after induction of differentiation, 2-day postconfluent (day 0) 3T3-L1 preadipocytes were treated with MDI in 10% FBS as above. At various times thereafter, cell monolayers (6-cm dishes) were washed once with cold PBS (pH 7.4) and then scraped into lysis buffer containing 1% SDS and 60 mM Tris⅐HCl (pH 6.8).
Lysates were heated at 100°C for 10 min, were clarified by centrifugation, and equal amounts of protein were subjected to SDS/PAGE and immunoblotting with antibodies against C/EBP␤, P-Thr 188 -C/EBP␤, ERK, P-ERK, and cdk2. Antibody against C/EBP␤ was prepared in this laboratory; antibody against P-Thr 188 -C/EBP␤ was from Cell Signaling Technology (Beverly, MA). Antibodies against MAPK and P-MAPK (Thr 202 /Tyr 204 ) were from Upstate Biotechnology (Lake Placid, NY). Antibody against cdk2 was from Santa Cruz Biotechnology (Santa Cruz, CA).
Preparation of Recombinant C/EBP␤(LAP) Protein. The cDNA encoding full-length C/EBP␤(LAP) protein was cloned downstream of the GST gene in pGEX-6P (Amersham Pharmacia Biotech, Piscataway, NJ) and transformed into Escherichia coli strain BL21(DE3)pLysS (Novagen, San Diego, CA). A single colony was propagated overnight in 3 ml of LB media containing ampicillin and chloramphenicol and was then diluted (1:100) into 500 ml of fresh LB media the next day and cultured until an A 600 of 0.6-0.7 was reached. Expression of the fusion proteins was induced by addition of 0.5 mM isopropyl ␤-D-thiogalactoside (IPTG) for 3 h, and the cells were harvested and resuspended in 25 ml of PBS containing 1% Triton X-100. After lysis by one cycle of freeze-thawing, the cell suspension was treated with DNase I and RNase A/T1 and then incubated on ice for 10 min in the presence of 0.5 M NaCl and 5 mM DTT to dissociate the DNA-protein complex. After centrifugation at 12,000 ϫ g for 10 min, 250-to 500-l bead volume of GSH-Sepharose (GE Healthcare, Piscataway, NJ) was added to the supernatate and mixed overnight at 4°C. Beads were washed three times with PBS, once with PreScission cleavage buffer (50 mM Tris-Cl, pH 7.5/150 mM NaCl/1 mM EDTA/1 mM DTT), and then treated with 80 units of PreScission Protease (GE Healthcare) in 960 l of buffer. The rC/EBP␤ cleavage product was further purified by CM-Sepharose chromatography (GE Healthcare), and after extensive washing with a low salt buffer, the highly purified recombinant protein eluted 250-300 mM of NaCl. Protein was
